1137950-10-7

Basic information

• Product Name: 6-(piperidin-4-yl)-[1,2,4]triazolo[4,3-a]pyridine
• Synonyms: 6-(piperidin-4-yl)-[1,2,4]triazolo[4,3-a]pyridine
• CAS NO: 1137950-10-7
• Molecular Formula: C11H14N4
• Molecular Weight: 202.25566
• Mol File: 1137950-10-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Density: 1.35±0.1 g/cm3(Predicted)
• PKA: 9.80±0.10(Predicted)
• CAS DataBase Reference: 6-(piperidin-4-yl)-[1,2,4]triazolo[4,3-a]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-(piperidin-4-yl)-[1,2,4]triazolo[4,3-a]pyridine(1137950-10-7)
• EPA Substance Registry System: 6-(piperidin-4-yl)-[1,2,4]triazolo[4,3-a]pyridine(1137950-10-7)

Safety Data

• Hazardous Substances Data: 1137950-10-7(Hazardous Substances Data)

Upstream product

• 1533440-71-9 tert-butyl 4-([1,2,4]triazolo[4,3-a]pyridin-6-yl)piperidine-1-carboxylate 

Relevant articles and documents

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

DIARYL KETIMINE DERIVATIVE HAVING ANTAGONISM AGAINST MELANIN-CONCENTRATING HORMONE RECEPTOR

[Problems] To provide an antagonist of a melanin-concentrating hormone receptor, which is useful as a medicine for a central nervous system disease, a cardiovascular disease or a metabolic disease. [Means for Solving Problems] The antagonist comprises, as an active ingredient, a compound represented by the formula (I) wherein R1a and R1b independently represent a hydrogen atom or a C1-6 alkyl group; R2a, R2b, R3a and R3b independently represent a hydrogen atom, a C1-6 alkyl group, or the like; Y represents H or —OH; Z represents —OR8, or the like; R8 represents a hydrogen atom, a C1-6 alkyl group which may have a substituent, or the like; R9a and R9b independently represent a hydrogen atom, a C1-6 alkyl group, or the like; Ar1 represents an aromatic carbon ring group, or an aromatic heteroring group; Ar2 represents a group produced by removing two hydrogen atoms from an aromatic carbon ring, or the like; and the ring group A represents an unsaturated heteroring group.